Label: ACNE TINTED SPOT TREATMENT- resorcinol, sulfur liquid
- NDC Code(s): 84262-023-01
- Packager: GLYTONE LLC
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated December 17, 2024
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Active Ingredients
- Purpose
- Use
-
Warnings
For external use only.
When using this product
- apply only to areas with acne
- rinse right away with water if it gets in eyes
- skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
-
Directions
- Cleanse the skin thoroughly before applying this product.
- Cover the affected area with a thin layer one to three times daily.
- Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor.
- If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
-
Inactive Ingredients
WATER, PROPYLENE GLYCOL. ALCOHOL DENAT., POLYSORBATE 20, CAPRYLIC/CAPRIC TRIGLYCERIDE, MAGNESIUM ALUMINUM SILICATE, SODIUM STEAROYL, GLUTAMATE, CETEARYL ALCOHOL, GLYCERYL SEARATE, POLYSORBATE 60, CHLOROXYLENOL, ETHYLHEXYLGLYCERIN, FRAGRANCE, PHENOXYETHANOL, POLYGLYCERYL-6 PALMITATE.SUCCINATE, XANTHAN GUM, IRON OXIDES, TITANIUM DIOXIDE
- Principal Display Panel
-
INGREDIENTS AND APPEARANCE
ACNE TINTED SPOT TREATMENT
resorcinol, sulfur liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:84262-023 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR 0.08 mg TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE 0.02 mg Inactive Ingredients Ingredient Name Strength POLYSORBATE 60 (UNII: CAL22UVI4M) CHLOROXYLENOL (UNII: 0F32U78V2Q) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) CETEARYL ALCOHOL (UNII: 2DMT128M1S) MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC) SODIUM STEAROYL GLUTAMATE (UNII: 65A9F4P024) IRON OXIDES (UNII: 1K09F3G675) PHENOXYETHANOL (UNII: HIE492ZZ3T) FARNESOL (UNII: EB41QIU6JL) CAPRYLIC/CAPRIC TRIGLYCERIDE (UNII: C9H2L21V7U) XANTHAN GUM (UNII: TTV12P4NEE) POLYGLYCERYL-4 PALMITATE (UNII: J6LAJ6FC55) WATER (UNII: 059QF0KO0R) GLYCERYL STEARATE (UNII: 230OU9XXE4) ALCOHOL (UNII: 3K9958V90M) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:84262-023-01 1 in 1 BOTTLE 03/01/2024 1 30 in 1 CARTON; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M006 03/01/2024 Labeler - GLYTONE LLC (119226548) Registrant - GLYTONE LLC (119226548)